WallStSmart

Trio-Tech International (TRT)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Trio-Tech International generates 858% more annual revenue ($58.34M vs $6.09M). TRT leads profitability with a 0.6% profit margin vs 0.0%. TRT earns a higher WallStSmart Score of 33/100 (F).

TRT

Avoid

33

out of 100

Grade: F

Growth: 4.7Profit: 3.5Value: 3.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.94

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TRTSignificantly Overvalued (-72.4%)

Margin of Safety

-72.4%

Fair Value

$3.44

Current Price

$10.45

$7.01 premium

UndervaluedFair: $3.44Overvalued
VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.23

$0.08 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TRT4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
123.6%10/10

Revenue surging 123.6% year-over-year

Debt/EquityHealth
0.1010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.9410/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

TRT4 concerns · Avg: 3.0/10
Market CapQuality
$106.59M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.6%3/10

ROE of 1.6% — below average capital efficiency

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : TRT

The strongest argument for TRT centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 123.6% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : TRT

The primary concerns for TRT are Market Cap, Return on Equity, Profit Margin. A P/E of 210.8x leaves little room for execution misses. Thin 0.6% margins leave little buffer for downturns.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

TRT profiles as a hypergrowth stock while VUZI is a value play — different risk/reward profiles.

TRT carries more volatility with a beta of 1.92 — expect wider price swings.

TRT is growing revenue faster at 123.6% — sustainability is the question.

TRT generates stronger free cash flow (707,000), providing more financial flexibility.

Bottom Line

TRT scores higher overall (33/100 vs 16/100) and 123.6% revenue growth. VUZI offers better value entry with a 40.5% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Trio-Tech International

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Trio-Tech International provides manufacturing, testing and distribution services to the semiconductor industry. The company is headquartered in Van Nuys, California.

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?